Skip to content

Pyramidal Versus Continuous Training Effects on Fatty Liver

Pyramidal Versus Continuous Training Effects on Fatty Liver

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06803108
Enrollment
38
Registered
2025-01-31
Start date
2024-08-01
Completion date
2025-02-28
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Brief summary

exercise is very important maneuver in the control of elevated liver enzymes in complaint of fatty liver .. the exercise forma are many.. from these exercises, pyramidal training or continues aerobic one.

Detailed description

the total participating subjects of the two groups of this study will be fatty liver subjects (19 subjects in every group). aerobic training on electronic treadmill will be adopted for 60 minutes in one group. In the other group, a pyramidal training will be adopted for nearly 60 minutes (nearly two rounds of 21 minutes of running on electronic treadmill will be separated with 10 minutes of rest between the two rounds. Also, warming (4 minutes before start of pyrimidal trianing) and cooling (4 minutes after pyramidal training) will be done through gentle stretching exercises/activities. the both forms of exercises will be done three times per week. the total study time will be 12 weeks. to be mentioned , the two groups followed low clorie diet

Interventions

BEHAVIORALpyramidal activity program

the participating subjects of this group of this study will be fatty liver subjects (19 subjects in this group). aerobic training on electronic treadmill will be adopted for 60 minutes in one group. In this group, a pyramidal training will be adopted for nearly 60 minutes (nearly two rounds of 21 minutes of running on electronic treadmill will be separated with 10 minutes of rest between the two rounds. Also, warming (4 minutes before start of pyrimidal trianing) and cooling (4 minutes after pyramidal training) will be done through gentle stretching exercises/activities. this form form of exercise will be done three times per week. the total study time will be 12 weeks. to be mentioned, the this group will follow low clorie diet

BEHAVIORALaerobic activity program

the participating subjects of the this group of this study will be fatty liver subjects (19 subjects in this group). aerobic training on electronic treadmill will be adopted for 60 minutes in this group with moderate intensity. the form of exercise will be done three times per week. the total study time will be 12 weeks. to be mentioned , this group will follow low clorie diet

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
37 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

* fatty liver patients * obese patients * all patients will class one obesity

Exclusion criteria

* cardiovascular complaint * metabolic complaints * othopedic pains in lower limbs

Design outcomes

Primary

MeasureTime frameDescription
alanine transamianseit will be measured after 12 weeksit is a liver enzyme

Secondary

MeasureTime frameDescription
alkaline phosphataseit will be measured after 12 weeksit is a liver enzyme
Gamma-glutamyl transferaseit will be measured after 12 weeksit is a liver enzyme
triglyceridesit will be measured after 12 weeksit will measured in serum
aspartate transaminaseit will be measured after 12 weeksit is a liver enzyme
body mass indexIt will be measured after 12 weeksit will be measured on empty stomach
waist circumferenceIt will be measured after 12 weeksit will be measured at level of umbilicus
high density lipoproteinit will be measured after 12 weeksit will measured in serum

Countries

Egypt

Contacts

Primary ContactAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
Backup Contactramy draz, lecturer
dr.ramy.salama@gmail.com01111534173

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026